Trump meets Novartis CEO, says drugmaker building 11 US plants
Chief Executive Officer Novartis Vas Narasimhan attends the 55th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January 22, 2025. REUTERS/Yves Herman
ROME, Georgia, Feb 19 (Reuters) - U.S. President Donald Trump said he met Vas Narasimhan, the chief executive officer of Swiss drugmaker Novartis, at the White House on Wednesday.
Trump, addressing workers at a steel plant in Rome, Georgia on Thursday, said Narasimhan told him during the meeting that his company was building 11 U.S. plants as a result of the president's tariff policies.
"We appreciate the opportunity to update the U.S. government on our progress, including recent groundbreakings for manufacturing and research facilities in North Carolina and California and plans to expand our radioligand therapy manufacturing network with a new site in Florida," a spokesperson for Novartis told Reuters in an emailed statement.
The statement did not add any details on the number of facilities planned in the U.S.
Last year, the Swiss drugmaker said it planned to spend $23 billion to build and expand 10 facilities in the U.S. after the Trump administration threatened to impose drug import duties.
(Reporting by Trevor Hunnicutt and Sneha SK, Additional reporting by Abu Sultan in Bengaluru; Writing by Andrea Shalal, Editing by Bhargav Acharya and Kate Mayberry)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump meets with travel industry CEOs on push to boost foreign tourism
- Explainer-What's next for Lindsay Clancy after mistrial?
- Factbox-Lindsay Clancy trial the latest high-profile murder case for Judge William Sullivan
Create E-mail Alert Related Categories
ReutersRelated Entities
Donald J. TrumpSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share